New Report Examines the Key to Success in Drug and Device Collaborations

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report on bio-device licensing which assesses the critical success factors in drug and device collaborations.

(PRWEB) July 6, 2008 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report on bio-device licensing which assesses the critical success factors in drug and device collaborations.

The report "Bio-Device Licensing Strategies for Success", available at http://tinyurl.com/64n9nr allows both device and pharmaceutical companies to maximise the benefit they achieve from these partnerships

Helping the reader to avoid the pitfalls of one-sided collaborations, the report answers important questions such as:

What do interdisciplinary collaborations really mean for device, biotech and pharmaceutical companies?
-Where can synergies be found and what are the challenges?[
-What are the next disruptive technologies?
-What are the emerging collaboration trends?
-What kind of partners are leading corporations seeking?
-How are valuable partnerships between large and small companies established?

The report "Bio-Device Licensing Strategies for Success" is available in pdf format from Piribo:
http://www.piribo.com/publications/medical_devices/biodevice_licensing_strategies_success.html

Piribo product ID: CLI001

About Piribo.
Piribo (http://www.piribo.com/publications/biotechnology) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 9,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###